Lupizotib 40mg Tablet

About

Lupizotib 40mg Tablet is a targeted therapeutic agent classified as a tyrosine kinase inhibitor (TKI). It exerts its antineoplastic effects by specifically blocking the activity of certain tyrosine kinases that play critical roles in the signaling pathways responsible for cancer cell growth, proliferation, and survival. By inhibiting these key enzymes, Lupizotib disrupts the abnormal cellular processes that drive tumor development, leading to reduced tumor growth and progression.

This precision medicine approach allows for a more focused attack on cancer cells, often resulting in improved efficacy and a potentially more favorable side effect profile compared to conventional cytotoxic chemotherapy. The effectiveness of Lupizotib is often dependent on the presence of specific molecular targets or mutations within the tumor, which are typically identified through diagnostic testing. Its oral formulation provides a convenient and accessible treatment option for patients, facilitating long-term adherence to therapy.

Uses

• Treatment of non-small cell lung cancer (NSCLC)
• Management of chronic myeloid leukemia (CML)
• Treatment of renal cell carcinoma (RCC)
• Management of gastrointestinal stromal tumors (GIST)

Directions For Use

Take orally once daily with or without food, as directed by your oncologist. Swallow the tablet whole; do not crush, chew, or split it.

Benefits

• Targets specific cancer-driving pathways
• Effective in various solid tumors and hematologic malignancies
• Improves progression-free survival
• Reduces tumor burden
• Oral administration for patient convenience
• Potential for fewer systemic side effects than traditional chemotherapy

Side Effects

• Diarrhea
• Fatigue
• Nausea
• Skin rash
• Hypertension
• Hand-foot syndrome
• Elevated liver enzymes
• Proteinuria
• Stomatitis
• Headache
• Abdominal pain
• Decreased appetite

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate liver toxicity associated with this medication.
• Pregnancy - Contraindicated during pregnancy due to potential teratogenic effects. Use effective contraception during and after treatment.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if the drug is excreted in breast milk and could harm the infant.
• Liver - Use with extreme caution in patients with liver impairment. Dose adjustments are often required, and liver function should be closely monitored.
• Kidney - Use with caution in patients with kidney conditions. Dose adjustments may be necessary based on renal function.
• Lung - Monitor for symptoms of interstitial lung disease (ILD). Use with caution in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.